SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000891293-21-000034
Filing Date
2021-06-17
Accepted
2021-06-17 16:50:56
Documents
4
Effectiveness Date
2021-06-17

Document Format Files

Seq Description Document Type Size
1 S-8 cti-formsx8xjune2021.htm S-8 84881
2 EX-4.1 exhibit41-amendedandrestat.htm EX-4.1 353247
3 EX-5.1 exhibit51.htm EX-5.1 8049
4 EX-23.2 exhibit232.htm EX-23.2 2408
  Complete submission text file 0000891293-21-000034.txt   449685
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-257174 | Film No.: 211025391
SIC: 2834 Pharmaceutical Preparations